Patrik Zintl

Patrik Zintl brings over 20 years of extensive experience in oncology and medical affairs to the table. He has held crucial roles in project leadership for drug development programs, global project management from Phase I to III, and oversight of late-phase projects such as observational and Market Access initiatives.

With a strong background in team leadership, Patrik is adept at handling office and department start-up activities. He has played pivotal roles in the successful approval and market launch of two oncology drugs, showcasing his expertise in driving projects to fruition.

Patrik Zintl's specialties span across various areas including oncology drug development, key opinion leader management, advisory board coordination, international congress preparation, sales team training, and market access strategies. His fluency in English, German, and Spanish, along with intermediate proficiency in French, has facilitated his international roles and engagements.

Having acquired his education from esteemed institutions such as AKG Bensheim, Ruprecht-Karls-Universit\u00e4t Heidelberg, and University College Cork, Patrik's academic foundation complements his extensive professional journey.

Throughout his career, Patrik has held key positions at renowned organizations including BeiGene, TESARO - GSK, Cell Therapeutics, Inc., PharmaMar, and Biomedical. His roles have ranged from Executive Director to Global Medical Director to Project Manager, reflecting his versatility and expertise in the field of oncology and medical affairs.